OR5P1P

Across TCGA pan-cancer cohorts, OR5P1P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated OR5P1P data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher OR5P1P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR5P1P expression acts as an unfavorable survival marker, although some lineages such as BLCA and STAD show a favorable association.

KICH, THCA, and PCPG are the cancer types where OR5P1P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Tertile	All	0.025	0.904	<.001	108	view →
THCA	DFS	Tertile	All	0.396	0.817	<.001	87	view →
PCPG	OS	Tertile	All	0.778	0.980	<.001	45	view →
COAD	OS	Tertile	III,IV	0.150	0.694	.003	36	view →
BLCA	DFS	Median	II,III,IV	0.429	0.295	.019	24	view →
SKCM	OS	Tertile	All	0.248	0.343	.040	9	view →
STAD	DFS	Tertile	IV	0.520	0.250	.033	9	view →
HNSC	DFS	Tertile	II,III,IV	0.820	0.675	.036	9	view →
KIRP	DFS	Tertile	All	0.719	0.920	.033	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

OR5P1P–KICH (DFS)

Open the KICH breakdown →